← TrialMatch
HomeTrials

QT-Digital Mental Health Engagement Study

Sexual and gender minority (SGM) populations are disproportionately impacted by mental health concerns relative to their heterosexual and cisgender peers. Despite high need, SGM populations continue to report unmet mental health needs because they cannot or do not access mental health services. Digital Mental Health (D

Condition(s)Engagement, Patient
StatusRecruiting
PhaseNA
Study typeInterventional
SummarySexual and gender minority (SGM) populations are disproportionately impacted by mental health concerns relative to their heterosexual and cisgender peers. Despite high need, SGM populations continue to report unmet mental health needs because they cannot or do not access mental health services. Digital Mental Health (DMH) services have been recognized as feasible, economical, and effective options to broaden the availability of mental health care to consumers who face barriers to mental health help-seeking. SGM consumers cite a preference for DMH care and this delivery format holds promise to attend to major mental health care access barriers experienced by this consumer group. Yet, the availability of DMH services tailored to the needs of SGM consumers is limited, and a dearth of research
Who can participateInclusion Criteria: * Users of the Mental Health America (MHA) website engaging from Internet Protocol (IP) addresses in the United States * Completed the PHQ-9 depression screener in English * Answered MHA's standard demographic questions that identify users as age 14 and older * Answered MHA's standard demographic questions that identify users as LGBTQ+. Exclusion Criteria: * IP addresses outside of the United States * Do not answer MHA's standard demographic questions * Answered MHA's standard demographic questions that identify users as age 13 and younger * Answered MHA's standard demographic questions that identify users as not LGBTQ+.
Ages14 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorUniversity of Washington
LocationsAlexandria, Virginia, United States; Seattle, Washington, United States
Start date2026-03-12
NCT IDNCT07278765
Official listinghttps://clinicaltrials.gov/study/NCT07278765

🔍 Search all trials →